NXERA

Business management, organisation and administration in the field of chemical products, biological products, pharmaceuticals, design and development of drugs, drug discovery; business management, organisation and administration in the field of research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; retail and wholesale services connected with the sale of pharmaceuticals, biological products and chemical and biological preparations.

Chemical products and proteins for manufacturing chemical and biological pharmaceutical products; chemical products and proteins for the research of chemical and biological pharmaceutical products; chemical products and proteins for diagnostic use, except medical or veterinary uses; proteins and Gprotein- coupled receptors for manufacturing pharmaceutical products; proteins and G-protein-coupled receptors for the research of pharmaceutical products; chemicals and proteins for chemical and biological drug discovery, lead identification and diagnostics; proteins and G-protein-coupled receptors for drug discovery purposes; chemicals and biologicals, including proteins, transmembrane proteins and G proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for chemical and biological drug discovery, lead identification and diagnostics; proteins, including transmembrane proteins and G-proteins, G-protein-coupled receptors, and fragments thereof being sequences of amino acids, for use in pharmaceutical research, including, drug discovery purposes.

Pharmaceutical preparations; medicines; biological products for medical purposes, namely, G-protein coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; biological products for use in chemical and biological drug discovery, lead identification and diagnostics; biological products for therapeutic purposes; biological formulation for developing chemical and biological pharmaceutical products; biological formulation for identifying lead chemical and biological products; biological formulation for diagnostic use; biological formulation for therapeutic use; proteins and G-protein-coupled receptors for drug discovery purposes; biologicals and small chemical entities, including proteins, G-protein-coupled receptors, modulators of G-protein coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for therapeutic purposes; proteins, Gprotein- coupled receptors, transmembrane proteins, G-proteins, antibodies and peptides for use in medical diagnostics.

Drug and pharmaceutical discovery services; bio-technology, pharmaceutical, chemical and medical testing, research, development, advice, consultancy and information services; research and development services in the pharmaceutical and biopharmaceutical fields, including technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in chemical and biological drug discovery and development; research and development services for identifying lead chemical compounds; examination and research services in medicinal and synthetic chemistry; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for screening purposes; research, analysis and examination for identification of compounds through automated screening processes; research and development services in chemical and biological pharmaceutical development; medical laboratory services; provision of information, advisory services and consultancy relating to the aforesaid services.

Pharmaceutical services; pharmaceutical advice and consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes; all of the aforesaid relating to drug discovery and use of Gprotein- coupled receptors in the design and development of pharmaceutical products.